A carregar...
Combinatorial approach to cancer immunotherapy: strength in numbers
Immune‐checkpoint blockade therapy with antibodies targeting CTLA‐4 and PD‐1 has revolutionized melanoma treatment by eliciting responses that can be remarkably durable and is now advancing to other malignancies. However, not all patients respond to immune‐checkpoint inhibitors. Extensive preclinica...
Na minha lista:
| Publicado no: | J Leukoc Biol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608090/ https://ncbi.nlm.nih.gov/pubmed/27256570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5RI0116-013RR |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|